Finance

Lists
Why is 2561 down 2.53%?
Dive Deeper
2561:HKG
Visen Pharmaceuticals
HK$18.52
-2.53%
(-0.48) 1D
Sep 29, 4:00:00 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2561...
Open
HK$18.50
High
HK$18.57
Low
HK$18.50
Mkt. cap
2.11B
Avg. vol.
10.36K
Volume
5.60K
52-wk high
HK$45.00
52-wk low
HK$18.50
EPS
-HK$2.35
No. of employees
102
Open
HK$18.50
High
HK$18.57
Low
HK$18.50
Mkt. cap
2.11B
Avg. vol.
10.36K
Volume
5.60K
52-wk high
HK$45.00
52-wk low
HK$18.50
EPS
-HK$2.35
No. of employees
102
About Visen Pharmaceuticals
CEO-
Employees102
Founded2018
Headquarters-
SectorBiotechnology
Websitevisenpharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
443.50K
443.50K
-375.50K
-375.50K
Cost of goods sold
-
-
73.00K
73.00K
Cost of revenue
-
-
73.00K
73.00K
Research and development expenses
23.31M
23.31M
23.43M
23.43M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
30.02M
30.02M
43.14M
43.14M
Operating expense
53.33M
53.33M
66.57M
66.57M
Total operating expenses
53.33M
53.33M
66.65M
66.65M
Operating income
-52.89M
-52.89M
-67.02M
-67.02M
Other non operating income
-5.01M
-5.01M
-306.50K
-306.50K
EBT including unusual items
-59.01M
-59.01M
-67.70M
-67.70M
EBT excluding unusual items
-59.01M
-59.01M
-67.70M
-67.70M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-59.01M
-59.01M
-67.70M
-67.70M
Net profit margin
-13,305.52%
-13,305.52%
18,029.56%
18,029.56%
Earnings per share
-
-
-
-
Interest and investment income
2.57M
2.57M
3.32M
3.32M
Interest expense
-19.50K
-19.50K
-529.50K
-529.50K
Net interest expenses
2.55M
2.55M
2.79M
2.79M
Depreciation and amortization charges
-
-
-
-
EBITDA
-52.80M
-52.80M
-66.91M
-66.91M
Gain or loss from assets sale
-361.50K
-361.50K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps